Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus.

Metabolism: clinical and experimental - 1 Jun 2001

Kordonouri O, James R W, Bennetts B, Chan A, Kao Y L, Danne T, Silink M, Donaghue K

Abstract excerpt

Paraoxonase (PON) is a high-density lipoprotein (HDL)-associated esterase, which may prevent the transformation of low-density lipoproteins (LDL) into biologically active, atherogenic particles. PON concentration and activity are affected by PON1 gene polymorphisms and found to be altered in type 2 diabetes patients with retinopathy. We investigated serum PON concentration, in vitro activity and polymorphism at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aryldialkylphosphatase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Glucose

Share to Diabetes Mellitus, Type 1

Share to Diabetic Retinopathy

Share to Esterases

Share to Genetic Predisposition to Disease

Share to Genotype

Source

Identifiers

PMID: 11398141
DOI: 10.1053/meta.2001.23291

Genes

PON1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus.PMID 11398141Read ↗

Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus.Semantic proximity Read ↗

A variant of paraoxonase (PON1) gene is associated with diabetic retinopathy in IDDM.Semantic proximity Read ↗

Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes.Semantic proximity Read ↗

Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.Semantic proximity Read ↗

Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus.Semantic proximity Read ↗

Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation.Semantic proximity Read ↗

Association between PON 1 polymorphisms, PON activity and diabetes complications.Semantic proximity Read ↗

Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?Semantic proximity Read ↗

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.Semantic proximity Read ↗

Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.Semantic proximity Read ↗

Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.Semantic proximity Read ↗

The relationship of PON1 QR 192 and LM 55 polymorphisms with serum paraoxonase activities of Turkish diabetic patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.